EncrypGen (DNA) Gets Listed on Kucoin


EncrypGen (DNA) Gets Listed on Kucoin

KuCoin is extremely proud to announce yet another great project coming to our trading platform. On January 26th, 2018  EncrypGen (token: DNA) was added to our list of tradable tokens.
KuCoin traders will have access to DNA/BTC and DNA/ETH trading pairs upon listing.
Users can start depositing and withdrawals on KuCoin January 26th,  2018 at 18:00(UTC +8), and trading DNA on KuCoin January 26th, 2018 at 22:00(UTC +8).
If you have any questions or doubt join our community and ask, we are always online: https://t.me/joinchat/FMqUpg1_vED9MSDJPPcFkg
Information – EncrypGen Store Your $DNA Footprint on the Blockchain
EncrypGen has taken blockchain technology and it’s applications to the next level. They have adapted their cryptocurrency and tailored it to the research industry. This unique application will provide users a safe place to store their $DNA and even monetize the information if they so choose.
The team at EncrypGen are fairly new to cryptocurrency, however, their application of the technology is groundbreaking. It was first demonstrated in Bio-IT Boston in May 2017. The original was built on its own multi-chain platform but has since been moved to the Ethereum network. With the rollout of the $DNA Token will also be Lite App that will allow users control over their genomic data.
The value of the tokens is derived from the sale of $DNA data to licensed institutions, and there are already a number of laboratories registered as clients to use the product; proving that others also see the potential in such a platform.
EncrypGen provides next-generation software for genomic data empowering patients and donors, facilitating health, business, and science in a safe environment.
Find out more about the projects: https://encrypgen.com/
Images courtesy of KuCoin
The post EncrypGen (DNA) Gets Listed on Kucoin appeared first on Bitcoinist.com.

Written by Bitcoinist.net @ http://bitcoinist.com/encrypgen-dna-gets-listed-kucoin/ January 26, 2018

Powered by WPeMatico

Comments are closed.